Evaluating the affect of Rapamycin in Alzheimer's disease (ERAP phase IIa clinical study protocol)

Reading this protocol is a nice summary of evidence to date for the use of Rapamycin to treat/prevent Alzheimer’s. I couldn’t find that someone else had posted this study protocol that came out in April 2024.

6 Likes

Very interesting, thanks for posting. As an ApoE4 homozygote I’m keeping my fingers crossed that rapamycin has a positive effect

2 Likes

This study will provide us longevity types a fair bit of information when it’s completed.

It’s design is very close to what many use as a longevity intervention and it has a lot of good references for those who are new to Rapa.

1 Like